Literature DB >> 17353383

Measures of adiposity and dementia risk in elderly persons.

José A Luchsinger1, Bindu Patel, Ming-Xin Tang, Nicole Schupf, Richard Mayeux.   

Abstract

BACKGROUND: Studies relating adiposity to dementia are conflicting. We explored the associations of body mass index (BMI), (calculated as weight in kilograms divided by the square of height in meters) waist circumference, and weight change to dementia, probable Alzheimer disease, and dementia associated with stroke (DAS).
DESIGN: Persons without dementia were followed up for 5 years; 893 persons had BMI data, 907 had waist circumference data, and 709 had a second weight measurement. Dementia was ascertained using standard methods. Cox proportional hazards regression was used for analyses using follow-up as time to event, adjusting for demographics and apolipoprotein E-epsilon4 status.
RESULTS: Compared with persons in the first quartile of BMI, persons in the third quartile had a lower dementia and Alzheimer disease risk and persons in the second quartile had a lower DAS risk. The association between BMI and dementia resembled a U shape in those younger than 76 years, while dementia risk decreased with higher BMI in those 76 years and older. The fourth quartile of waist circumference was related to a higher DAS risk in the whole sample, and to dementia and Alzheimer disease in persons younger than 76 years. Weight loss was related to a higher dementia and DAS risk, and weight gain was related to a higher DAS risk only.
CONCLUSIONS: The prospective association between adiposity and dementia differs depending on the anthropometric measure used, and is modified by age. This may explain previous conflicting reports.

Entities:  

Mesh:

Year:  2007        PMID: 17353383      PMCID: PMC1821350          DOI: 10.1001/archneur.64.3.392

Source DB:  PubMed          Journal:  Arch Neurol        ISSN: 0003-9942


  61 in total

1.  The origins of Alzheimer disease: a is for amyloid.

Authors:  D J Selkoe
Journal:  JAMA       Date:  2000 Mar 22-29       Impact factor: 56.272

2.  Body mass index and incidence of dementia: the PAQUID study.

Authors:  F Nourhashémi; V Deschamps; S Larrieu; L Letenneur; J-F Dartigues; P Barberger-Gateau
Journal:  Neurology       Date:  2003-01-14       Impact factor: 9.910

3.  Diabetes mellitus and the risk of dementia: The Rotterdam Study.

Authors:  A Ott; R P Stolk; F van Harskamp; H A Pols; A Hofman; M M Breteler
Journal:  Neurology       Date:  1999-12-10       Impact factor: 9.910

4.  New NHLBI clinical guidelines for obesity and overweight: will they promote health?

Authors:  W J Strawbridge; M I Wallhagen; S J Shema
Journal:  Am J Public Health       Date:  2000-03       Impact factor: 9.308

5.  An 18-year follow-up of overweight and risk of Alzheimer disease.

Authors:  Deborah Gustafson; Elisabet Rothenberg; Kaj Blennow; Bertil Steen; Ingmar Skoog
Journal:  Arch Intern Med       Date:  2003-07-14

Review 6.  Hypertension, hypertension-clustering factors and Alzheimer's disease.

Authors:  Ingmar Skoog; Deborah Gustafson
Journal:  Neurol Res       Date:  2003-09       Impact factor: 2.448

7.  Increased risk of type 2 diabetes in Alzheimer disease.

Authors:  Juliette Janson; Thomas Laedtke; Joseph E Parisi; Peter O'Brien; Ronald C Petersen; Peter C Butler
Journal:  Diabetes       Date:  2004-02       Impact factor: 9.461

8.  Insulin-degrading enzyme regulates the levels of insulin, amyloid beta-protein, and the beta-amyloid precursor protein intracellular domain in vivo.

Authors:  Wesley Farris; Stefan Mansourian; Yang Chang; Loren Lindsley; Elizabeth A Eckman; Matthew P Frosch; Christopher B Eckman; Rudolph E Tanzi; Dennis J Selkoe; Suzanne Guenette
Journal:  Proc Natl Acad Sci U S A       Date:  2003-03-12       Impact factor: 11.205

9.  Decompensated heart failure: symptoms, patterns of onset, and contributing factors.

Authors:  Gordon D Schiff; Sharon Fung; Theodore Speroff; Robert A McNutt
Journal:  Am J Med       Date:  2003-06-01       Impact factor: 4.965

Review 10.  The role of cerebrovascular disease in dementia.

Authors:  Charles DeCarli
Journal:  Neurologist       Date:  2003-05       Impact factor: 1.398

View more
  90 in total

1.  Apolipoprotein epsilon 4 allele modifies waist-to-hip ratio effects on cognition and brain structure.

Authors:  David Zade; Alexa Beiser; Regina McGlinchey; Rhoda Au; Sudha Seshadri; Carole Palumbo; Philip A Wolf; Charles DeCarli; William Milberg
Journal:  J Stroke Cerebrovasc Dis       Date:  2011-08-10       Impact factor: 2.136

Review 2.  Obesity, insulin resistance, and Alzheimer's disease.

Authors:  Kerry L Hildreth; Rachael E Van Pelt; Robert S Schwartz
Journal:  Obesity (Silver Spring)       Date:  2012-02-07       Impact factor: 5.002

3.  Obesity and central obesity as risk factors for incident dementia and its subtypes: a systematic review and meta-analysis.

Authors:  M A Beydoun; H A Beydoun; Y Wang
Journal:  Obes Rev       Date:  2008-03-06       Impact factor: 9.213

Review 4.  Adiposity and Alzheimer's disease.

Authors:  José A Luchsinger; Deborah R Gustafson
Journal:  Curr Opin Clin Nutr Metab Care       Date:  2009-01       Impact factor: 4.294

Review 5.  Estrogen: a master regulator of bioenergetic systems in the brain and body.

Authors:  Jamaica R Rettberg; Jia Yao; Roberta Diaz Brinton
Journal:  Front Neuroendocrinol       Date:  2013-08-29       Impact factor: 8.606

Review 6.  Nutrition and neurodegeneration: epidemiological evidence and challenges for future research.

Authors:  Sophie Gillette-Guyonnet; Marion Secher; Bruno Vellas
Journal:  Br J Clin Pharmacol       Date:  2013-03       Impact factor: 4.335

7.  Body mass index over the adult life course and cognition in late midlife: the Whitehall II Cohort Study.

Authors:  Séverine Sabia; Mika Kivimaki; Martin J Shipley; Michael G Marmot; Archana Singh-Manoux
Journal:  Am J Clin Nutr       Date:  2008-12-10       Impact factor: 7.045

8.  Adiposity indicators and dementia over 32 years in Sweden.

Authors:  D R Gustafson; K Bäckman; M Waern; S Ostling; X Guo; P Zandi; M M Mielke; C Bengtsson; I Skoog
Journal:  Neurology       Date:  2009-11-10       Impact factor: 9.910

Review 9.  Adiposity, hyperinsulinemia, diabetes and Alzheimer's disease: an epidemiological perspective.

Authors:  José Alejandro Luchsinger
Journal:  Eur J Pharmacol       Date:  2008-03-04       Impact factor: 4.432

10.  Body mass index, lifestyles, physical performance and cognitive decline: the "Treviso Longeva (TRELONG)" study.

Authors:  M Gallucci; S Mazzuco; F Ongaro; E Di Giorgi; P Mecocci; M Cesari; D Albani; G L Forloni; E Durante; G B Gajo; A Zanardo; M Siculi; L Caberlotto; C Regini
Journal:  J Nutr Health Aging       Date:  2013-04       Impact factor: 4.075

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.